rogaron lemon sugar free
abic marketing ltd, israel - benzydamine hydrochloride - lozenges - benzydamine hydrochloride 3 mg - benzydamine - rogaron is used for symptomatic local treatment of acute sore throat in adults and children over 6 years of age.
rogaron orange - honey sugar free
abic marketing ltd, israel - benzydamine hydrochloride - lozenges - benzydamine hydrochloride 3 mg - benzydamine - rogaron is used for symptomatic local treatment of acute sore throat in adults and children over 6 years of age.
scenesse
dor pharmaceutical services ltd., israel - afamelanotide as acetate - implant - afamelanotide as acetate 16 mg - afamelanotide - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).
dorzolamide/timolol
actavis group ptc ehf - dorzolamide ; timolol - eye drops solution - 20+5 mg/ml - timolol, combinations
dorzolamide + timolol pharmaswiss 20 mg/ml + 5 mg/ml, eye drops solution
pharmaswiss ceska republika s.r.o. - dorzolamide hydrochloride; timolol maleate - eye drops, solution - 20mg/ml+5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations
repaglinide teva 0.5 mg
teva pharmaceutical industries ltd, israel - repaglinide - tablets - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.
repaglinide teva 1 mg
teva pharmaceutical industries ltd, israel - repaglinide - tablets - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.
dexacort forte
teva pharmaceutical industries ltd, israel - dexamethasone sodium phosphate - solution for injection - dexamethasone sodium phosphate 20 mg/ml - dexamethasone - dexamethasone - intravenous use as adjunctive treatment of severe shock of hemorrhagic, traumatic, surgical or septic origin.
copaxone 20 mgml
teva pharmaceutical industries ltd, israel - glatiramer acetate - solution for injection - glatiramer acetate 20 mg/dose - glatiramer acetate - glatiramer acetate - for reducing the frequency of relapses in pateints with relapsing-remitting multiple sclerosis. copaxone is indicated for the treatment of patients who have experienced a well defined first clinical episode and are determined to be at high risk of developing clinically definite multiple sclerosis (cdms). these patients should have mri findings which are compatible with the diagnosis of multiple sclerosis.
acamoli forte 250 mg5 ml syrup tutti-frutti flavour
teva pharmaceutical industries ltd, israel - paracetamol - syrup - paracetamol 250 mg / 5 ml - paracetamol - paracetamol - analgesic, antipyretic.